FDA Drug Application (017531) for TIGAN by KING PHARMS

Back to FDA Applications sponsored by KING PHARMS

Application Number017531
Product Number006
FormCAPSULE;ORAL
Dosage300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTIGAN
Active IngredientTRIMETHOBENZAMIDE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient TRIMETHOBENZAMIDE HYDROCHLORIDE3


Back to FDA Applications sponsored by KING PHARMS